InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient de ...

An international research team has developed perovskite solar cells and mini-modules with a 2D/3D heterojunction architecture ...

Since the 1980s, researchers have sought to use laser light to control chemical reactions relevant to photochemistry, catalysis and light-responsive materials. But this technique, known as coherent ...

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.

Incyte (Nasdaq:INCY) today reports 2023 second quarter financial results, and provides a status update on the Company's clinical development portfolio. "We delivered ...

A major new study has found that mental health and behavioural changes such as depression, anxiety, and emotional instability are common in people who survive encephalitis — inflammation of the brain ...